These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 15034505)

  • 1. Chemoprevention of squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: results of a phase 1 trial of systemic isotretinoin.
    Fine JD; Johnson LB; Weiner M; Stein A; Suchindran C
    J Am Acad Dermatol; 2004 Apr; 50(4):563-71. PubMed ID: 15034505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa-Hallopeau-Siemens: a report of four cases.
    Dammak A; Zribi J; Boudaya S; Mseddi M; Meziou TJ; Masmoudi A; Ellouze Z; Keskes H; Turki H
    Int J Dermatol; 2009 Jun; 48(6):588-91. PubMed ID: 19538366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of squamous cell carcinoma in a patient with recessive-type epidermolysis bullosa dystrophica.
    Yamada M; Hatta N; Sogo K; Komura K; Hamaguchi Y; Takehara K
    Dermatol Surg; 2004 Nov; 30(11):1424-9. PubMed ID: 15522026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Squamous cell carcinoma secondary to recessive dystrophic epidermolysis bullosa: report of eight tumours in four patients.
    Bosch RJ; Gallardo MA; Ruiz del Portal G; Snchez P; Arce MF; Herrera E
    J Eur Acad Dermatol Venereol; 1999 Nov; 13(3):198-204. PubMed ID: 10642056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas.
    Kivisaari AK; Kallajoki M; Mirtti T; McGrath JA; Bauer JW; Weber F; Königová R; Sawamura D; Sato-Matsumura KC; Shimizu H; Csikós M; Sinemus K; Beckert W; Kähäri VM
    Br J Dermatol; 2008 Apr; 158(4):778-85. PubMed ID: 18284387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of sentinel node biopsy in the management of squamous cell carcinoma arising from recessive dystrophic epidermolysis bullosa.
    Rokunohe A; Nakano H; Aizu T; Kaneko T; Nakajima K; Ikenaga S; Matsuzaki Y; Murai T; Tamai K; Sawamura D
    J Dermatol; 2008 Jun; 35(6):336-40. PubMed ID: 18578710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma complicating epidermolysis bullosa in a 6-year-old girl.
    Shivaswamy KN; Sumathy TK; Shyamprasad AL; Ranganathan C
    Int J Dermatol; 2009 Jul; 48(7):731-3. PubMed ID: 19570079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis.
    Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J
    Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA and epidermolysis bullosa. Association between the HLA complex and recessive dystrophic epidermolysis bullosa.
    Vaidya S; Tyring SK; Johnson LB; Fine JD
    Arch Dermatol; 1991 Oct; 127(10):1524-7. PubMed ID: 1929459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the pathogenesis of recessive dystrophic epidermolysis bullosa squamous cell carcinoma.
    South AP; O'Toole EA
    Dermatol Clin; 2010 Jan; 28(1):171-8. PubMed ID: 19945632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Squamous cell carcinoma complicating an hereditary epidermolysis bullosa].
    Mseddi M; Turki H; Marrekchi S; Abdelmaksoud W; Masmoudi A; Bouassida S; Zahaf A
    Cancer Radiother; 2004 Aug; 8(4):266-9. PubMed ID: 15450521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cetuximab therapy of metastasizing cutaneous squamous cell carcinoma in a patient with severe recessive dystrophic epidermolysis bullosa.
    Arnold AW; Bruckner-Tuderman L; Zuger C; Itin PH
    Dermatology; 2009; 219(1):80-3. PubMed ID: 19439919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anchorless keratinocyte survival: an emerging pathogenic mechanism for squamous cell carcinoma in recessive dystrophic epidermolysis bullosa.
    Rodeck U; Fertala A; Uitto J
    Exp Dermatol; 2007 Jun; 16(6):465-7. PubMed ID: 17518985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients with recessive dystrophic epidermolysis bullosa in the Netherlands: expansion of the mutation database and unusual phenotype-genotype correlations.
    van den Akker PC; van Essen AJ; Kraak MM; Meijer R; Nijenhuis M; Meijer G; Hofstra RM; Pas HH; Scheffer H; Jonkman MF
    J Dermatol Sci; 2009 Oct; 56(1):9-18. PubMed ID: 19665875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inherited epidermolysis bullosa and the risk of death from renal disease: experience of the National Epidermolysis Bullosa Registry.
    Fine JD; Johnson LB; Weiner M; Stein A; Cash S; DeLeoz J; Devries DT; Suchindran C;
    Am J Kidney Dis; 2004 Oct; 44(4):651-60. PubMed ID: 15384016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of cutaneous pinch grafts in the healing of patients with dystrophic epidermolysis bullosa wounds: report of four cases].
    Claude O; Binder JP; Bustamante K; Blanchet-Bardon C; Andrivon F; Revol M; Servant JM
    Ann Chir Plast Esthet; 2005 Jun; 50(3):189-96. PubMed ID: 15963838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recessive dystrophic epidermolysis bullosa-associated squamous-cell carcinoma: an enigmatic entity with complex pathogenesis.
    Rodeck U; Uitto J
    J Invest Dermatol; 2007 Oct; 127(10):2295-6. PubMed ID: 17853916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Squamous cell cancers in Hallopeau-Siemens recessive dystrophic epidermolysis bullosa].
    Otte HG; Stieler W; Anton-Lamprecht I
    Hautarzt; 1990 Sep; 41(9):494-8. PubMed ID: 2249946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trial of retinol and isotretinoin in skin cancer prevention: a randomized, double-blind, controlled trial. Southwest Skin Cancer Prevention Study Group.
    Levine N; Moon TE; Cartmel B; Bangert JL; Rodney S; Dong Q; Peng YM; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):957-61. PubMed ID: 9367070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral isotretinoin in the treatment and prevention of cutaneous squamous cell carcinoma.
    Jones E; Korzenko A; Kriegel D
    J Drugs Dermatol; 2004; 3(5):498-502. PubMed ID: 15552602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.